Showing results (241-250 of 358) with videos related to
Sort By:
Pageof 36
Alimentary Pharmacology & Therapeutics|June 18, 2024
Systematic review: Patient-related, microbial, surgical, and histopathological risk factors for endoscopic post-operative recurrence in patients with Crohn's diseaseMichiel T J Bak, Karlijn Demers, Nassim Hammoudi, et al.Mucosal Immunology|December 17, 2008
Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesisP Goyette, C Lefebvre, A Ng, et al.Ebiomedicine|July 3, 2017
The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only StudyM Ellen Kuenzig, Jeff Yim, Stephanie Coward, et al.The American Journal of Gastroenterology|December 12, 2012
Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics ConsortiumMark Lazarev, Chengrui Huang, Alain Bitton, et al.Clinical and Translational Gastroenterology|January 17, 2014
Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel diseaseSandeep S Dhillon, Lucas A Mastropaolo, Ryan Murchie, et al.Journal of Crohn'S & Colitis|March 31, 2021
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE StudyBrian Bressler, Andres Yarur, Mark S Silverberg, et al.Inflammatory Bowel Diseases|August 31, 2016
Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium StudyUri Kopylov, Gabrielle Boucher, Matti Waterman, et al.Frontiers in Immunology|August 21, 2023
The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell populationTiago S Medina, Alex Murison, Michelle Smith, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 15, 2026
Real-World Outcomes of Upadacitinib Versus Risankizumab Among Anti-TNF Exposed Patients with Crohn's DiseaseCathy McShane, Pablo A Olivera, Kristina Candido, et al.Journal of Crohn'S & Colitis|October 26, 2021
A Role for CXCR3 Ligands as Biomarkers of Post-Operative Crohn's Disease RecurrenceMargaret Walshe, Shadi Nayeri, Jiayi Ji, et al.Pageof 36